drugset / Trial / NCT04168099
Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis
Timeline
- Start
- 2018-12-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cefotaxime | Small molecule | — | Intravenous |
| Comparator | Gemifloxacin | Small molecule | — | Oral |